Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jun '25 Jun 6, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	Aug '20 Aug 31, 2020	2018 - 2019
Market Capitalization	110	61	90	118	149	70	Upgrade
Market Cap Growth	41.79%	-32.29%	-23.64%	-20.54%	112.60%	-36.02%	Upgrade
Enterprise Value	154	105	131	146	160	74	Upgrade
Last Close Price	1.20	0.68	1.00	1.35	1.70	0.95	Upgrade
PE Ratio	8.64	9.51	13.02	51.35	-	-	Upgrade
PS Ratio	1.17	0.75	1.58	3.30	8.75	27.48	Upgrade
PB Ratio	1.16	0.70	1.13	1.77	2.32	1.83	Upgrade
P/TBV Ratio	1.16	0.70	1.13	1.77	2.32	1.84	Upgrade
P/FCF Ratio	24.20	19.05	-	-	-	-	Upgrade
P/OCF Ratio	10.16	5.73	15.29	-	-	-	Upgrade
EV/Sales Ratio	1.63	1.28	2.29	4.07	9.40	29.09	Upgrade
EV/EBITDA Ratio	6.80	7.62	7.92	16.91	58.11	-	Upgrade
EV/EBIT Ratio	9.53	13.69	11.17	30.25	3041.19	-	Upgrade
EV/FCF Ratio	33.86	32.55	-	-	-	-	Upgrade
Debt / Equity Ratio	0.52	0.55	0.57	0.73	0.33	0.34	Upgrade
Debt / EBITDA Ratio	2.16	3.45	2.75	5.54	7.15	-	Upgrade
Debt / FCF Ratio	10.78	15.04	-	-	-	-	Upgrade
Asset Turnover	0.61	0.55	0.43	0.33	0.23	0.04	Upgrade
Inventory Turnover	1.33	1.41	1.14	1.40	1.39	1.09	Upgrade
Quick Ratio	0.64	0.73	0.70	1.75	1.63	2.32	Upgrade
Current Ratio	2.35	2.50	2.44	3.46	2.82	3.03	Upgrade
Return on Equity (ROE)	15.44%	7.68%	9.48%	3.52%	-2.98%	-29.66%	Upgrade
Return on Assets (ROA)	6.55%	3.23%	5.48%	2.77%	0.04%	-12.16%	Upgrade
Return on Capital (ROIC)	7.41%	3.65%	6.09%	3.01%	0.05%	-13.06%	Upgrade
Return on Capital Employed (ROCE)	12.40%	6.00%	9.70%	4.20%	0.10%	-	Upgrade
Earnings Yield	12.21%	10.52%	7.68%	1.95%	-1.03%	-17.81%	Upgrade
FCF Yield	4.13%	5.25%	-4.39%	-18.20%	-22.26%	-26.41%	Upgrade
Buyback Yield / Dilution	-1.66%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%	Upgrade

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.